Amide-Substituted Pyridine Derivatives for Targeted ACSS2 Inhibition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer therapies lack effective inhibitors for acetyl-CoA synthetase 2 (ACSS2), which is highly expressed in cancer tissues and contributes to tumor growth and proliferation, particularly under hypoxic conditions.
Innovation Solution
Development of amide derivatives that act as inhibitors of ACSS2, specifically compounds of formula I-a, I-b, or I-c, which can be in the form of N-oxides, solvates, tautomers, stereoisomers, or pharmaceutically acceptable salts, with varying aromatic and heteroaromatic substituents to enhance inhibitory activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current cancer therapies are used, then general tumor treatment is achieved, but effective inhibition of ACSS2 enzyme is not obtained
Solution Approach 1:
The patent applies parameter changes by systematically modifying molecular parameters of the compounds - specifically changing the core heterocyclic structure (imidazo[4,5-b]pyridine, pyrazolo[1,5-a]pyridine, imidazo[1,2-a]pyridine), varying substituent groups (R1-R6 positions), and adjusting molecular weight and lipophilicity parameters to optimize ACSS2 binding affinity and selectivity, thereby achieving effective ACSS2 inhibition
Solution Approach 2:
The patent segments the molecule into distinct functional regions: a core heterocyclic aromatic ring system (providing rigid structural framework), amide functional groups (providing hydrogen bonding capability), and variable substituent groups (R1-R6, providing steric and electronic modulation). This segmentation allows independent optimization of each region for ACSS2 enzyme interaction
2Productivity
If ACSS2 is highly expressed in cancer tissues, then tumor growth and proliferation are promoted, but targeted inhibition becomes challenging
Solution Approach 1:
The patent converts the harmful effect of ACSS2 overexpression (which drives tumor growth under hypoxic conditions) into a therapeutic opportunity by designing selective ACSS2 inhibitors that specifically target and inhibit this upregulated enzyme, thereby converting the cancer-promoting pathway into a vulnerability that can be exploited for cancer treatment
Solution Approach 2:
The patent introduces small molecule inhibitor compounds as intermediaries that bind to the ACSS2 enzyme active site, blocking acetate activation without affecting other metabolic pathways. These molecular intermediaries specifically interrupt the ACSS2-mediated acetate metabolism pathway that is hijacked by cancer cells for biosynthesis and energy production
Data Source
AI summary
The present invention relates to substituted amide derivatives. These compounds are useful for the prevention and/or treatment of several medical conditions including hyperproliferative disorders and diseases.